Danish Bawa

Danish Bawa

Auto-generated profile, based on publicly available information

Danish Bawa

Midwest Heart and Vascular Specialist HCA Midwest Overland Park Kansas USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2024 in JACC: Advances
Verified
Journal Article
Open access
DLDhanunjaya Lakkireddy
Dhanunjaya Lakkireddy
AAAdnan Ahmed
Adnan Ahmed
DBDanish Bawa
Danish Bawa
JGJalaj Garg
Jalaj Garg
DADonita Atkins
Donita Atkins
ANAndrea Natale
Andrea Natale
Atrial fibrillation (AF) is the most common arrhythmia reported worldwide. There is significant heterogeneity in AF care pathways for a patient seen in the emergency room, impacting access to guideline-driven therapies. The purpose of this study was to compare the difference in AF outcomes between those treated with an organized treatment pathway vs routine-care approach. The emergency room to electrophysiology service study (ER2EP) is a multicenter, prospective observational registry (NCT04476524) enrolling patients with AF from sites where a pathway for management of AF was put in place compared to sites where a pathway was not in place within the same health system and the same physicians providing services at all sites. Multivariable regression modeling was performed to identify predictors of clinical outcomes. Beta coefficient or odds ratio was reported as appropriate. A total of 500 patients (ER2EP group, n = 250; control group, n = 250) were included in the study. The mean age was 73.4 ± 12.9 years, and 52.2% were males. There was a statistically significant difference in primary endpoint [time to ablation (56 ± 50.9 days vs 183.3 ± 109.5 days; P < 0.001), time to anticoagulation initiation (2.1 ± 1.6 days vs 19.7 ± 35 days, P < 0.001), antiarrhythmic drug initiation (4.8 ± 7.1 days vs 24.7 ± 44.4 days, P < 0.001) compared to the control group, respectively. As such, this resulted in reduced length of stay in the ER2EP group compared to the control group (2.4 ± 1.4 days vs 3.23 ± 2.5 days, P = 0.002). This study provides evidence that having an organized pathway from the emergency department for AF patients involving electrophysiology services can improve early access to definitive therapies and clinical outcomes.

28 August 2025 in JACC: Advances
Verified
Journal Article
Open access
DBDanish Bawa
Danish Bawa
RGRachad Ghazal
Rachad Ghazal
RKRajesh Kabra
Rajesh Kabra
NPNicholas Pham
Nicholas Pham
AAAdnan Ahmed
Adnan Ahmed
DLDhanunjaya Lakkireddy
Dhanunjaya Lakkireddy
Remote monitoring (RM) is the standard of care for patients with cardiac implantable electronic devices (CIEDs). Data deluge from RM of CIEDs is one of the major challenges being faced by cardiac device clinics. The purpose of this study was to highlight the role of artificial intelligence (AI) in reducing data deluge from CIEDs and to elucidate its performance in augmenting the traditional device clinic workforce. Deidentified data from RM of CIEDs from 78 device clinics across the United States were included. Transmissions processed by AI and device technicians (DTs) were compared. Around 15% of all transmissions processed were examined at random by 2 cardiac electrophysiologists who were blinded to the source of the interpretation. Over 8 months, 690,673 transmissions were generated from RM of 74,217 devices. AI processed 28.3% of the transmissions, whereas DT processed 71.7% (n = 495,054). AI forwarded 22.8% (n = 44,550) while DT forwarded 38.5% (n = 190,492) of the total processed transmissions to the device clinics. As such, only 34% (n = 235,042) of the total transmissions were forwarded to the device clinics. Considering electrophysiologist interpretation/adjudication as the gold standard, AI was 93.8% accurate with 99.1% sensitivity, 93% specificity, and an F1 score of 81%. This study presents a real-world analysis of incorporating AI in device clinic workflow to assist in interpretation and classification of RM data. AI interpretation of transmissions was found to have an accuracy similar to that of DT with superior sensitivity but lesser specificity.

21 August 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
AAAdnan Ahmed
Adnan Ahmed
RGRachad Ghazal
Rachad Ghazal
DBDanish Bawa
Danish Bawa
DDDouglas Darden
Douglas Darden
SKScott Koerber
Scott Koerber
NPNaga Venkata K. Pothineni
Naga Venkata K. Pothineni

29 June 2022
Verified
Preprint
Open access
PDF file
DBDanish Bawa
Danish Bawa
JAJavaria Ahmad
Javaria Ahmad
ASAakash Rajendra Sheth
Aakash Rajendra Sheth
SRSahith Thotamgari R
Sahith Thotamgari R
APAshritha Penagaluri
Ashritha Penagaluri
PDPaari Dominic
Paari Dominic
Catheter Ablation of Atrial Fibrillation (AF) in patients with heart failure with reduced ejection fraction (HFrEF) is associated with decreased all-cause mortality, and improvement in left ventricular ejection fraction (EF). Predictors of EF improvement post-AF ablation is not known. In this study we conducted a retrospective review of patients who underwent catheter ablation for AF within last 6 years. 82 Patients undergoing catheter ablation for paroxysmal or persistent AF with EF <45% were included in the study, 18 patients were lost to follow up and therefore were excluded. The patients were divided into 2 groups based on presence or absence of 5% improvement in LVEF post CA, compared to LVEF obtained prior to CA. Mean improvement in EF after ablation was 17±11.8%. As compared to baseline, EF improved by at least 5% in 80% (n=51) of the patients who underwent ablation. Patients with improved EF had significantly higher average total voltage in the LA compared to patients who had no improvement in EF (1.70±1.16 vs 1.00±0.82, p=0.02*). In the multivariable model, after adjusting for other risk factors, LA average total voltage was significantly higher in the group with improved EF (p=0.04*).

15 June 2026 in Clinical Cardiology
Verified
Journal Article
Open access
ESEmad Uddin Sajid
Emad Uddin Sajid
MAMuhammad Hasnain Azeem
Muhammad Hasnain Azeem
AFAlishba Fatima
Alishba Fatima
SJSyeda Masooma Jafri
Syeda Masooma Jafri
DHDanish Hassan
Danish Hassan
DBDanish Bawa
Danish Bawa
Background: High‐intensity statins are standard therapy after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS), yet tolerability concerns and residual cardiovascular risk remain important challenges. Moderate‐intensity statin therapy combined with ezetimibe has emerged as a potential alternative, although its comparative effectiveness after PCI remains uncertain. Methods: We performed a systematic review and meta‐analysis according to PRISMA guidelines. PubMed, Cochrane Library, and ClinicalTrials.gov were searched through September 2025 for studies enrolling adults undergoing PCI and comparing moderate‐intensity statin plus ezetimibe therapy with high‐intensity statin therapy. The primary outcome was major adverse cardiovascular events (MACE), defined as all‐cause mortality, myocardial infarction (MI), stroke, and revascularization. Secondary outcomes included individual cardiovascular endpoints and safety outcomes such as new‐onset diabetes and rhabdomyolysis. Random‐effects models were used to calculate pooled risk ratios (RRs). Results: Nine studies involving 179 621 patients were included, the majority being observational studies. No significant difference was observed in MACE between treatment strategies (RR 0.96, 95% CI 0.81–1.12). Modest reductions were observed in cardiovascular mortality (RR 0.83, 95% CI 0.71–0.98) and MI (RR 0.74, 95% CI 0.58–0.95), although findings were non‐robust with wide prediction intervals. Revascularization rates were similar between groups. Subgroup analyses suggested lower heterogeneity in intermediate follow‐up and non‐ACS populations. Conclusions: Moderate‐intensity statin plus ezetimibe therapy may provide cardiovascular outcomes comparable to high‐intensity statins after PCI. However, persistent heterogeneity limits certainty, and large randomized trials are needed to confirm long‐term efficacy and safety.

1 December 2023 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
RGRachad Ghazal
Rachad Ghazal
AAAdnan Ahmed
Adnan Ahmed
DBDanish Bawa
Danish Bawa
NPNicholas Pham
Nicholas Pham
VSVasvi Singh
Vasvi Singh
DLDhanunjaya Lakkireddy
Dhanunjaya Lakkireddy